| A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia (NCT07758920) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2026-08-01 |
| Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS (NCT07413094) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2026-02-02 |
| Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery (NCT07311369) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-12-01 |
| Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain (NCT07159243) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-09-01 |
| A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (NCT07174115) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-08-18 |
| Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery (NCT07147049) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-08-08 |
| Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants (NCT06912295) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-03-21 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in Healthy Subjects (NCT07098091) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-02-26 |
| HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer (NCT05728619) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2023-02-03 |